These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 37562083)

  • 1. Inability to work following COVID-19 vaccination-a relevant aspect for future booster vaccinations.
    Reusch J; Wagenhäuser I; Gabel A; Höhn A; Lâm TT; Krone LB; Frey A; Schubert-Unkmeir A; Dölken L; Frantz S; Kurzai O; Vogel U; Krone M; Petri N
    Public Health; 2023 Sep; 222():186-195. PubMed ID: 37562083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sick leave request following anti-COVID-19 vaccine administration is low among healthcare workers: results from a retrospective cross-sectional monocentric study.
    Schianchi A; Ughi N; Cassano G; Del Gaudio F; Dicuonzo A; Scaglione F; Alberti PM; Rossetti C; Micheloni G; Zoppini L; Bellavia G; Giroldi S; Moreno M; Russo A; Bosio M; Epis OM
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7218-7222. PubMed ID: 34919220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Vaccination and Asymptomatic Infection: Effect of BNT162b2 mRNA Vaccine on the Incidence of COVID-19 and Duration of Sick Leave Among Healthcare Workers.
    Prato' S; Paladino ME; Riva MA; Belingheri M
    J Occup Environ Med; 2021 Dec; 63(12):e868-e870. PubMed ID: 34538839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.
    Desmecht S; Tashkeev A; El Moussaoui M; Marechal N; Perée H; Tokunaga Y; Fombellida-Lopez C; Polese B; Legrand C; Wéry M; Mni M; Fouillien N; Toussaint F; Gillet L; Bureau F; Lutteri L; Hayette MP; Moutschen M; Meuris C; Vermeersch P; Desmecht D; Rahmouni S; Darcis G
    Front Immunol; 2022; 13():863554. PubMed ID: 35711445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of mRNA vaccines in curtailing SARS-CoV-2 infection and disability leave utilisation among healthcare workers during the COVID-19 pandemic: cross-sectional analysis from a tertiary healthcare system in the Greater Houston metropolitan area.
    Vahidy FS; Pan AP; Hagan K; Bako AT; Sostman HD; Schwartz RL; Phillips R; Boom ML
    BMJ Open; 2021 Oct; 11(10):e054332. PubMed ID: 34642201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody response after a third dose mRNA-1273 vaccine among vaccinated healthcare workers with two doses of inactivated SARS-CoV-2 vaccine.
    Cucunawangsih C; Wijaya RS; Lugito NPH; Suriapranata I
    Int J Infect Dis; 2022 May; 118():116-118. PubMed ID: 35192955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [COVID-19 infections and effectiveness of the vaccination among healthcare workers].
    Rojkovich B; Németh D; Dinya E; Nagy E; Török E; Lázár I; Perduk A; Géher P; Nagy G
    Orv Hetil; 2023 Feb; 164(5):163-171. PubMed ID: 36739547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary SARS-CoV-2 Infections, Re-infections and Vaccine Effectiveness during the Omicron Transmission Period in Healthcare Workers of Trieste and Gorizia (Northeast Italy), 1 December 2021-31 May 2022.
    Cegolon L; Negro C; Mastrangelo G; Filon FL;
    Viruses; 2022 Nov; 14(12):. PubMed ID: 36560692
    [No Abstract]   [Full Text] [Related]  

  • 9. Waning of humoral immunity depending on the types of COVID-19 vaccine.
    Lim SY; Kim JY; Jung J; Yun SC; Kim SH
    Infect Dis (Lond); 2023 Mar; 55(3):216-220. PubMed ID: 36625442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination, time lost from work, and COVID-19 infections: a Canadian healthcare worker retrospective cohort study.
    Okpani AI; Lockhart K; Grant JM; Barker S; Srigley JA; Yassi A
    Front Public Health; 2023; 11():1214093. PubMed ID: 37608982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 booster vaccination uptake and infection breakthrough amongst health care workers in Wales: A national prospective cohort study.
    Bedston S; Lowthian E; Jarvis CI; Akbari A; Beggs J; Bradley D; de Lusignan S; Griffiths R; Herbert L; Hobbs R; Kerr S; Lyons J; Midgley W; Owen RK; Quint JK; Tsang R; Torabi F; Sheikh A; Lyons RA
    Vaccine; 2023 Feb; 41(7):1378-1389. PubMed ID: 36669966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the COVID-19 pandemic on sick leave among healthcare workers: a register-based observational study.
    Reme BA; Grøsland M; Gjefsen H; Magnusson K
    Occup Environ Med; 2023 Jun; 80(6):319-325. PubMed ID: 37068949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Durability of anti-spike antibodies after vaccination with mRNA SARS-CoV-2 vaccine is longer in subjects with previous infection: could the booster dose be delayed?
    Stellini R; Gianello R; Gomarasca W
    Infection; 2022 Dec; 50(6):1573-1577. PubMed ID: 35391649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional study.
    Martin CA; Marshall C; Patel P; Goss C; Jenkins DR; Ellwood C; Barton L; Price A; Brunskill NJ; Khunti K; Pareek M
    PLoS Med; 2021 Nov; 18(11):e1003823. PubMed ID: 34739480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020-31 January 2023.
    Cegolon L; Magnano G; Negro C; Larese Filon F;
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515237
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of COVID-19 vaccine-associated side effects on health care worker absenteeism and future booster vaccination.
    Chrissian AA; Oyoyo UE; Patel P; Lawrence Beeson W; Loo LK; Tavakoli S; Dubov A
    Vaccine; 2022 May; 40(23):3174-3181. PubMed ID: 35465979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibody Response After Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthcare Workers with and without Previous COVID-19 Infection: A Prospective Observational Study].
    Özgür D; Tütüncü EE
    Mikrobiyol Bul; 2022 Jan; 56(1):36-48. PubMed ID: 35088958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody responses and SARS-CoV-2 infection after BNT162b2 mRNA booster vaccination among healthcare workers in Japan.
    Igari H; Asano H; Murata S; Yoshida T; Kawasaki K; Kageyama T; Ikeda K; Koshikawa H; Okuda Y; Urushihara M; Chiba H; Yahaba M; Taniguchi T; Matsushita K; Yoshino I; Yokote K; Nakajima H
    J Infect Chemother; 2022 Nov; 28(11):1483-1488. PubMed ID: 35870791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance data.
    Paris C; Perrin S; Hamonic S; Bourget B; Roué C; Brassard O; Tadié E; Gicquel V; Bénézit F; Thibault V; Garlantézec R; Tattevin P
    Clin Microbiol Infect; 2021 Nov; 27(11):1699.e5-1699.e8. PubMed ID: 34265462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 infection after COVID-19 immunization in healthcare workers: A retrospective, pilot study.
    Vaishya R; Sibal A; Malani A; Prasad KH
    Indian J Med Res; 2021 May&Jun; 153(5&6):550-554. PubMed ID: 34341227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.